The 75% Conversion Myth

Why Most Orthodontic Practices Are Measuring the Wrong Number

“Industry standard is 75%.”

If your treatment coordinator is below that number, it feels like underperformance. If you are above it, you feel safe.

But 75% of what?

Because when we look closer, most practices are not actually measuring true consult-to-start conversion. They are measuring a blended production outcome and calling it conversion.

And that misunderstanding quietly distorts growth planning.

Let’s bring clarity back to the math.

What 75% Usually Includes 

In many practices, “conversion rate” is calculated as:

Total starts in a month ÷ Total exams in that same month

On the surface, that feels logical.

But look at what is buried inside that numerator.

Your total starts likely include:

• Patients who consulted this month and started immediately

• Patients who were sitting in pending (short or long term) and decided to move forward

• Phase II starts

• Observation patients who converted

That means you are dividing mixed-source starts by this month’s exams.

This number is not measuring how well your TC converts consults.

It is measuring how your entire pipeline performed that month.

Those are two very different things.

And when you use a blended metric to set growth goals, you lose precision.

A More Useful Question: What Actually Converts in Your Practice?

Instead of asking whether you are hitting 75%, we encourage you to ask two cleaner questions:

1. Out of all exams, what percentage of patients are offered treatment?

2. Of those offered treatment, how many start within 60 days?

Now we are isolating behavior. Now we are measuring influence. Now we can actually plan.

For many orthodontic practices, the real number looks like this:

• 100 consults

• 60-70 patients offered treatment

• 45-50 patients starting within 60 days

  
  

That is a 45-50% true short-term conversion rate.

And that is not failure. That is reality.

When you understand your actual patient behavior trends, you stop chasing a mythical benchmark and start building a reliable forecast.

Why This Distinction Matters for Growth

If you believe you convert at 75%, you might assume:

“To get 45 starts, we only need 60 consults.”

But if your real 60-day conversion rate is 45%, then:

To get 45 starts, you need 100 consults.

That is a very different marketing target.

That is a very different scheduling plan.

When you base production forecasting on blended metrics, you wait for the pipeline to fill and hope it performs.

When you base forecasting on true consult behavior, you can reverse engineer growth in real time.

Step 1: Separate Pipeline from Performance

Start tracking three distinct numbers:

• Exams completed

• Treatment plans presented

• Starts within 60 days of consult

Do not mix pending, Phase II, or observation conversions into your short-term consult metric.

Those matter. But they are pipeline management, not TC conversion.

Clarity creates control.

Step 2: Identify Your Offer Rate

If 100 patients come in for exams but only 65 are offered treatment, you do not have a TC issue. You may have a high number of pediatric referrals and patients going into observation. 

Understanding your offer rate separates clinical philosophy from financial performance.

And it helps you align your growth plan with your treatment approach.

Step 3: Track 60-Day Starts Religiously

Why 60 days?

Because that window reflects short-term influence.

After 60 days, starts often reflect:

• Financial timing

• Life events

• Insurance resets

• Phase transitions

If your goal is proactive growth, you must know what happens within 60 days of the consult.

That number tells you whether your current marketing volume will produce next quarter’s

production.

Step 4: Reverse Engineer with Real Math

Once you know your true 60-day conversion rate, growth becomes mechanical.

If your 60-day conversion rate is 45%:

• 30 starts = 67 consults

• 45 starts = 100 consults

• 60 starts = 133 consults

Now marketing and schedule targets align. 

You are no longer guessing. You are engineering.

The Leadership Shift: From Hope to Forecast

When conversion is misunderstood, growth feels like a rollercoaster.

When the conversion rate is managed in this new way, growth becomes structural.

You can forecast:

• How many NP exams you need

• How many doctor days are required

• Whether marketing is underperforming or simply underfunded

This is how proactive practices operate. Not by chasing industry averages. But by knowing their own data deeply.

Where CascadEffects Steps In

This is exactly where fractional COO leadership creates leverage.

We help you:

• Define clean, meaningful metrics

• Separate pipeline noise from true performance

• Align marketing targets to actual production math

Once you understand your real numbers, you stop reacting to last month’s production and start building next quarter’s outcome intentionally.

Let’s replace industry myths with operational clarity.

Let’s reverse engineer your targets using real patient trends.

Let’s build a practice that grows because it is designed to, not because it got lucky.

Author: Casey Bull | casey@cascadeffects.com